Paris, – Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GenoSplice Technology, developers of bioinformatics solutions for analysis of genomic data, today announce they have formed a partnership to combine their expertise. This collaboration will provide GenoSplice with access to several Curie-Cancer technology platforms to allow it to continue to improve […]
Palo Alto, CA — Syapse, the leader in bringing omics into routine medical use, announced unprecedented momentum in helping laboratories and clinics generate and use next-generation sequencing to diagnose and treat patients. Syapse software is now involved in the processing of over 3,000 patient genomes and thousands of transcriptome, proteome, immunome, and microbiome profiles per […]
Roche enhances its lineup of IT solutions for the professional medical laboratory and today unveils cobas IT middleware, a software suite for fully automated workflow management. Enabling laboratory managers to easily link multiple laboratory systems and software with their IT infrastructure, cobas IT middleware takes over autonomous coordination of laboratory routine processes. More than a […]
FOSTER CITY, CA –– Silicon Valley Biosystems (SV Bio), a diagnostics company founded to provide rapid, accurate, and turnkey clinical interpretation of comprehensive genomics data at the point of care to improve the health and outcomes of patients, was launched today. Backed by Sequoia Capital, a premier venture capital firm that helped to build Apple, […]
Hilden, Germany, and Germantown, Maryland, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced submission of its therascreen® EGFR RGQ PCR Kit (therascreen EGFR test) to the U.S. Food and Drug Administration (FDA) as a proposed companion diagnostic to guide treatment with afatinib, a new investigational oncology compound developed by Boehringer Ingelheim. Afatinib […]
Franklin Lakes, NJ – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the BD PhaSeal™ Closed System Transfer Device (CSTD) under the newly created ONB code. The BD PhaSeal System is the first and […]
AUSTIN, Texas, — Luminex Corporation (NASDAQ: LMNX) announced today that it has received FDA clearance for its xTAG Gastrointestinal Pathogen Panel (GPP), the first comprehensive molecular diagnostic assay that tests for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single assay. The xTAG GPP assay can be an important […]
SUNNYVALE, Calif., — Cepheid (NASDAQ: CPHD) today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid’s Xpert® CT/NG test as ‘Moderate Complexity’ under the Clinical Laboratory Improvement Amendments (CLIA). Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). The […]
FREMONT, Calif — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific QMS Everolimus Assay Kit has been CE marked for sale in the European Union for a third application, namely liver transplants. This new indication allows laboratories to monitor blood levels of everolimus, the active ingredient in […]
WALTHAM, Mass. & REDWOOD CITY, Calif — PerkinElmer, Inc. (NYSE: PKI) and Verinata Health, Inc., today announced a strategic agreement for expanding access to Verinata’s verifi® test, the most comprehensive non-invasive prenatal test (NIPT) currently available for high-risk pregnancies. The verifi® test, which is performed at Verinata’s CLIAcertified, California laboratory, uses a single maternal blood […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
